Velocity Clinical Research

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials

Phase

• Phase 22 trials
• Phase 1/21 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Regor Pharmaceuticals Inc.2 trials
• Currax Pharmaceuticals1 trial
• ModernaTX, Inc.1 trial

Running trials

• Active, not recruiting

  Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

  NCT06098079· Phase 4· Currax Pharmaceuticals· Source

• Active, not recruiting

  A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

  NCT05164094· Phase 1/2· ModernaTX, Inc.· Source

Closed trials

• Completed

  Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

  NCT06867718· Phase 2· Regor Pharmaceuticals Inc.· Source

• Completed

  A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

  NCT06277934· Phase 2· Regor Pharmaceuticals Inc.· Source